EUROPEAN OPEN ELECTRONIC PROCEDURE TENDER FOR THE FOUR-YEAR SUPPLY OF REAGENTS FOR NGS ANALYSIS INVESTIGATIONS, DIVIDED INTO 3 LOTS
LOT-0001
reagents intended for molecular investigations based on NGS sequencing technology, for the analysis of fusion transcripts, mutations (SNP, INDEL) and CNV of genes involved in onco-hematological diseases.
reagents intended for molecular investigations based on NGS sequencing technology, for the analysis of fusion transcripts, mutations (SNP, INDEL) and CNV of genes involved in onco-hematological diseases
LOT-0002
reagents intended for molecular investigations based on NGS sequencing technology, for determining the presence or absence of clonality and somatic hypermutation and for monitoring minimal residual disease in B and T cell lymphoproliferative diseases.
reagents intended for molecular investigations based on NGS sequencing technology, for determining the presence or absence of clonality and somatic hypermutation and for monitoring minimal residual disease in B and T cell lymphoproliferative diseases
LOT-0003
reagents for next-generation sequencing (NGS) intended for the creation of custom assays for the analysis of point mutations (SNV), insertions/deletions (Indel), copy number variations (CNV) and fusion transcripts in genes involved in onco-hematological diseases, including a software platform for secondary and tertiary bioinformatics analysis.
reagents for next-generation sequencing (NGS) intended for the creation of custom assays for the analysis of point mutations (SNV), insertions/deletions (Indel), copy number variations (CNV) and fusion transcripts in genes involved in onco-hematological diseases, including a software platform for secondary and tertiary bioinformatics analysis